Kiniksa Pharma 13D Filing
Kiniksa Pharmaceuticals International, plc files amended Schedule 13D with the SEC. The filing indicates a change in beneficial ownership.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.